ENCISION INC
ECIAHealthcare · Surgical & Medical Instruments & Apparatus · CO · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $6.6M | $6.6M | $7.3M | $7.7M | $7.5M | $7.7M |
| Operating income | −$171,980 | −$640,783 | −$302,797 | −$594,934 | −$61,641 | −$156,360 |
| Net income | −$220,198 | −$691,783 | −$323,945 | −$65,594 | $584,734 | −$198,312 |
| Total assets | $3.7M | $3.8M | $4.1M | $4.8M | $5.7M | $4.7M |
| Total liabilities | $2.0M | $2.0M | $1.6M | $2.0M | $2.9M | $2.6M |
| Equity | $1.7M | $1.8M | $2.5M | $2.7M | $2.8M | $2.2M |
| EPS (diluted) | $-0.02 | $-0.06 | $-0.03 | $-0.01 | — | — |
| Shares out. | 11.9M | 11.9M | 11.8M | 11.7M | 11.6M | 11.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −2.6%
- Net margin
- −3.4%
- Return on equity
- −13.3%
- Return on assets
- −6.0%
- Return on capital (ROCE)
- −8.2%
- Liabilities / assets
- 55.0%
- Debt / equity
- 1.22×
- Book value / share
- $0.14
- Revenue growth (YoY)
- −0.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -17.82distress
- Accruals / assets
- −4.5%clean
- Beneish M-Score
- -2.96normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
- NT 10-Kmissed a reporting deadline ↗Jun 30, 2025
- NT 10-Kmissed a reporting deadline ↗Jul 1, 2024
- NT 10-Qmissed a reporting deadline ↗Feb 14, 2024
- NT 10-Kmissed a reporting deadline ↗Jun 29, 2022
- NT 10-Kmissed a reporting deadline ↗Jul 2, 2001
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Shepard Brandon JasonActivist (13D)Aug 26, 2025
- Trudel Gregory J.Activist (13D)Aug 26, 2025
- Fries Robert HActivist (13D)Aug 26, 2025
- Thalassa Holdings LtdActivist (13D)Mar 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 22,520 | 1000.0 | 0.0% |
| Apr 30, 2026 | 22,520 | 7.7 | +152.5% |
| Apr 15, 2026 | 8,919 | 1.0 | +100.0% |
| Jan 30, 2026 | 5,353 | 1.0 | -50.7% |
| Jan 15, 2026 | 10,851 | 1.8 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventJan 29, 2026
- Director / officer changeDec 12, 2025
- Director / officer changeNov 3, 2025
- Entered a material agreement · Unregistered equity sale · Shareholder vote · Regulation FD disclosureAug 22, 2025
- Shareholder voteAug 15, 2024
- Results of operationsAug 15, 2024
- Results of operationsJul 15, 2024
- Director / officer changeApr 23, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4PRIMARY DOCUMENTMay 18, 2026
- EFFECTFeb 9, 2026
- EFFECTFeb 4, 2026
- S-8 POSFeb 4, 2026
- S-8 POSFeb 4, 2026
- S-8 POSFeb 4, 2026
- S-8 POSFeb 4, 2026
- POS AMFeb 4, 2026
- POS AMFeb 4, 2026
- 15-12GFORM 15-12GJan 29, 2026
- 8-KFORM 8-KJan 29, 2026
- 8-KFORM 8-KDec 12, 2025
- 4PRIMARY DOCUMENTNov 20, 2025
- 4PRIMARY DOCUMENTNov 20, 2025
- 4PRIMARY DOCUMENTNov 20, 2025